T-DXd
-
ASCO Express: From “low expression” to “even lower expression”, the best-selling ADC enters the next level!
Following the FDA’s accelerated approval of Enhertu (trastuzumab deruxtecan, …
Following the FDA’s accelerated approval of Enhertu (trastuzumab deruxtecan, …